The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis

被引:2
|
作者
Welsh, Silje [1 ,2 ]
Sam, Zihao [1 ,2 ]
Seenan, John Paul [2 ,3 ]
Nicholson, Gary A. [2 ,3 ]
机构
[1] Univ Edinburgh, Edinburgh Med Sch Clin Sci, Edinburgh, Midlothian, Scotland
[2] NHS Greater Glasgow & Clyde, Gen Surg & Gastroenterol Dept, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Med Sch, Glasgow, Lanark, Scotland
关键词
appendicectomy; ulcerative colitis; inflammatory bowel disease; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL NEOPLASIA; APPENDIX; RISK; THERAPY; COLECTOMY; PREDICTORS; PROTECTS; COHORT;
D O I
10.1093/ibd/izac127
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background This updated systematic review and meta-analysis investigates the putative role of the appendix in ulcerative colitis as a therapeutic target. Methods Ovid Medline, Embase, PubMed and CENTRAL were searched with MeSH terms ("appendectomy" OR "appendicitis" OR "appendix") AND ("colitis, ulcerative") through October 2020, producing 1469 references. Thirty studies, including 118 733 patients, were included for qualitative synthesis and 11 for quantitative synthesis. Subgroup analysis was performed on timing of appendicectomy. Results are expressed as odds ratio (OR) with 95% confidence intervals (CIs). Results Appendicectomy before UC diagnosis reduces the risk of future colectomy (OR, 0.76; 95% CI, 0.65-0.89; I-2 = 5%; P = .0009). Corresponding increased risk of colorectal cancer and high-grade dysplasia are identified (OR, 2.27; 95% CI, 1.11-4.66; P = .02). Significance is lost when appendicectomy is performed after disease onset. Appendicectomy does not affect hospital admission rates (OR, 0.87; 95% CI, 0.68-1.12; I-2 = 93%; P = .27), steroid use (OR, 1.08; 95% CI, 0.78-1.49; I-2 = 36%; P = .64), immunomodulator use (OR, 1.04; 95% CI, 0.76-1.42; I-2 = 19%; P = .79), or biological therapy use (OR, 0.76; 95% CI, 0.44-1.30; I-2 = 0%; P = .32). Disease extent and risk of proximal progression are unaffected by appendicectomy. The majority (71% to 100%) of patients with refractory UC avoid colectomy following therapeutic appendicectomy at 3-year follow-up. Conclusions Prior appendicectomy reduces risk of future colectomy. A reciprocal increased risk of CRC/HGD may be due to prolonged exposure to subclinical colonic inflammation. The results warrant further research, as consideration may be put toward incorporating a history of appendicectomy into IBD surveillance guidelines. A potential role for therapeutic appendicectomy in refractory left-sided UC is also identified. Lay Summary This article was written as part of a higher degree with the University of Edinburgh. The first author received the Association of Surgeons in Training (ASiT) Edinburgh Surgery Online Bursary during the completion of the degree and this journal article. This updated systematic review finds appendicectomy before ulcerative colitis (UC) diagnosis reduces risk of future colectomy but increases the risk of colorectal malignancy. Incorporating a history of appendicectomy into IBD surveillance guidelines could be considered. A potential role for therapeutic appendicectomy in left-sided treatment refractory UC is also identified.
引用
收藏
页码:633 / 646
页数:14
相关论文
共 50 条
  • [1] The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis
    Welsh, Silje
    Sam, Zihao
    Seenan, John Paul
    Nicholson, Gary A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : E147 - E148
  • [2] The role of laparoscopic surgery for ulcerative colitis: systematic review with meta-analysis
    Xiao-Jian Wu
    Xiao-Sheng He
    Xu-Yu Zhou
    Jia Ke
    Ping Lan
    [J]. International Journal of Colorectal Disease, 2010, 25 : 949 - 957
  • [3] The role of laparoscopic surgery for ulcerative colitis: systematic review with meta-analysis
    Wu, Xiao-Jian
    He, Xiao-Sheng
    Zhou, Xu-Yu
    Ke, Jia
    Lan, Ping
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (08) : 949 - 957
  • [4] Moxibustion for ulcerative colitis: a systematic review and meta-analysis
    Dong-Hyo Lee
    Jong-In Kim
    Myeong Soo Lee
    Tae-Young Choi
    Sun-Mi Choi
    Edzard Ernst
    [J]. BMC Gastroenterology, 10
  • [5] Moxibustion for ulcerative colitis: a systematic review and meta-analysis
    Lee, Dong-Hyo
    Kim, Jong-In
    Lee, Myeong Soo
    Choi, Tae-Young
    Choi, Sun-Mi
    Ernst, Edzard
    [J]. BMC GASTROENTEROLOGY, 2010, 10
  • [6] Multiple sclerosis and ulcerative colitis: A systematic review and meta-analysis
    Nabizadeh, Fardin
    Azizi, Ali
    Hejrati, Lina
    Mousavi, Maryam
    Mehranzadeh, Ali
    Badihian, Shervin
    Tavallaei, Mohammad Javad
    Rahmanian, Vahid
    Amiri, Bahareh Shateri
    Rafiei-Sefiddashti, Raheleh
    Hejrati, Alireza
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (03)
  • [7] Infliximab therapy in ulcerative colitis: Systematic review and meta-analysis
    Gisbert, J.
    Gonzalez-Lama, Y.
    Mate, J.
    [J]. INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 662 - 662
  • [8] USE OF ANTIBIOTICS IN ULCERATIVE COLITIS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Jha, DayaKrishna
    Mishra, Shubhra
    Singh, Anupam K.
    Kumar-M, Praveen
    Patil, Amol
    Sharma, Vishal
    [J]. GUT, 2020, 69 : A49 - A49
  • [9] Colectomy rates in ulcerative colitis: A systematic review and meta-analysis
    Dai, Nick
    Haidar, Omar
    Askari, Alan
    Segal, Jonathan P.
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 (01) : 13 - 20
  • [10] COLECTOMY RATES IN ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Dai, Nick
    Haidar, Omar
    Askari, Alan
    Segal, Jonathan
    [J]. GUT, 2022, 71 : A45 - A45